Precision Diagnostics
Clinical Intelligence Hub • Expert Curation
Precision diagnostic profiling translates to proactive disease screening and biological age optimization. Our clinical board reviews advanced epigenetic clocks (like OMICm Age, Symphony Organ Age, and Dunedin Pace) and circulating tumor DNA (ctDNA) liquid biopsies. Early detection allows you to manage systemic aging risks years before they manifest.
Understand how a polygenic risk score stroke prevention strategy can identify hidden cardiovascular vulnerabilities and guide personalized medical interventions.
Explore how blood protein biomarkers map the precise molecular pathways linking metabolic stress to cardiovascular and neurological organ complications.
Discover how brain-derived plasma pTau217 assays revolutionize early Alzheimer's detection by identifying silent amyloid accumulation years before symptoms.
Learn how ALFAssay, an innovative neural network, utilizes advanced liquid biopsy diagnostics to precisely quantify circulating tumor DNA fragments in blood.
Discover how advanced epigenetic methylation metrics monitor the biological tension between smoking and diet to guide personal biological age rejuvenation.
Discover how clinical trials targeting systemic tissue aging leverage structured exercise and cellular pharmacology to rebuild mitochondrial capacity.
Discover how a breakthrough 320-protein panel acts as a real-time GPS for cardiovascular health, predicting heart and kidney disease years before symptoms.
Is artificial intelligence in breast imaging ready for clinical practice? New studies reveal a deep divide between technological promise and patient trust.
A groundbreaking study reveals how a single urinary biomarker can team up with traditional PSA tests to drastically improve prostate screening accuracy.